MM cells generating various inflammatory cytokines, such as TNF-α, IL-6, and IL-1β, and the interaction between myeloma cells and bone microenvironment modulate osteoclast differentiation and osteoblast inhibition [6]. This evidence concerns the gene IL6 and Miyoshi myopathy.